Core Viewpoint - The introduction of the "1+6" policy and supporting business rules for the Sci-Tech Innovation Board (STAR Market) is facilitating the acceleration of core technology breakthroughs and industrialization processes for many unprofitable listed companies [1][2][3]. Group 1: Impact on Companies - Companies like Zejing Pharmaceutical have successfully launched multiple innovative drugs since their listing, benefiting from the supportive policies aimed at hard-tech enterprises [1]. - Aibi Zhongguang, which went public in an unprofitable state, anticipates turning profitable by Q1 2025, attributing its growth to the increasingly accommodating financing environment of the capital market [1]. - Tuojing Technology, focusing on high-end semiconductor equipment, achieved profitability in its first year post-listing, demonstrating the positive impact of the STAR Market platform [1]. Group 2: Policy Benefits - The establishment of the Sci-Tech Growth Layer and the resumption of the fifth listing standard are seen as measures that cater to the needs of technology innovation enterprises, allowing for a more patient capital approach towards companies with key technologies and clear growth paths [2][3]. - The reforms are expected to reshape valuation logic, emphasizing long-term value indicators such as technological maturity and market development potential, particularly for hard-tech sectors like semiconductors and biomedicine [2]. - The policies are designed to alleviate financing pain points for tech companies, enabling a more rational assessment of technological accumulation and long-term potential rather than focusing solely on short-term profitability [3].
科创板多家上市时未盈利公司发声——资本市场开辟专属通道 有助于核心技术攻关
Zheng Quan Shi Bao·2025-07-13 18:42